Michael B Hoffman insider trades

Open-market stock purchases and sales by Michael B Hoffman, Chairman and CEO at Translational Development Acquisition Corp, from SEC Form 4 filings since Jul 25, 2013.

Track record: 6% of 16 scored buys are up 5% or more since purchase, averaging -37%.

Recent trades

DateStockTradeValue
May 27, 2026TDAC Translational Development Acquisition CorpBought$42.3K
May 20, 2026ANVS Annovis Bio, IncBought$4.5K
May 20, 2026ANVS Annovis Bio, IncBought$33.9K
May 20, 2026ANVS Annovis Bio, IncBought$104K
Apr 2, 2026ANVS Annovis Bio, IncBought$1.5M
Dec 8, 2025ANVS Annovis Bio, IncBought$130K
Dec 8, 2025ANVS Annovis Bio, IncBought$63.6K
Nov 24, 2025ANVS Annovis Bio, IncBought$117K
Nov 24, 2025ANVS Annovis Bio, IncBought$6.1K
Nov 24, 2025ANVS Annovis Bio, IncBought$35.4K
Nov 24, 2025ANVS Annovis Bio, IncBought$1.7K
Nov 24, 2025ANVS Annovis Bio, IncBought$6.1K
Nov 24, 2025ANVS Annovis Bio, IncBought$35.4K
Nov 24, 2025ANVS Annovis Bio, IncBought$1.7K
Nov 24, 2025ANVS Annovis Bio, IncBought$117K
Nov 21, 2025ANVS Annovis Bio, IncBought$35K
Nov 14, 2025ANVS Annovis Bio, IncBought$31.6K
Oct 28, 2025ANVS Annovis Bio, IncBought$2M

Companies traded

  • TDAC Translational Development Acquisition Corp: 1 buy, last May 27, 2026
  • ANVS Annovis Bio, Inc: 18 buys, last May 20, 2026
  • ONTX Onconova Therapeutics, Inc: 12 buys, 6 sales, last Aug 27, 2020

Get free alerts when Michael B Hoffman files a new trade →